Sign in
CompletedNo phase

Management of Postpartum Preeclampsia

Key facts

Who runs it
Rutgers, The State University of New Jersey
Where
Livingston and New Brunswick, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
392 people enrolled
Started
28 Mar 2023
Ended
26 Mar 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Tight postpartum blood pressure control
Record updated
2 April 2024

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Chronic hypertension, gestational hypertension, or preeclampsia
  • Delivery of a neonate after 20 weeks during their current hospitalization
  • Able to consent
  • 18 years old or above
  • English or Spanish speaking
  • Planning to follow up with a physician associated with Robert Wood Johnson University Hospital or Cooperman Barnabas Medical Center
  • Ability to follow directions

Who cannot take part

  • Any medical condition that the providers feel is a contraindication to the MOPP algorithm
  • Planning to follow up with an outside institution
  • Unwillingness to take blood pressure at home

Where in United States

  • Cooperman Barnabas Medical CenterLivingston, United States
  • Robert Wood Johnson Medical SchoolNew Brunswick, United States

About the trial

What the trial wants to find out

The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.

The 2 groups in the trial

  • Prospective interventional armTreatment being tested

    The prospective cohort will identify patients in the postpartum period of their delivery hospitalization who are at risk of readmission for hypertensive disorders in the initial six weeks postpartum. Those at risk include patients with diagnosed with chronic hypertension or PIH. Chronic hypertension is defined as either taking antihypertensive medications or a blood pressure of greater than or equal to 140/90 mm Hg prior to 20 weeks of gestation. Pregnancy induced hypertension includes gestational hypertension, preeclampsia without severe features, preeclampsia with severe features and Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP). The minimum requirement to be diagnosed with this spectrum of disorders is having two blood pressures of greater than or equal to 140/90 mm Hg during the antepartum, intrapartum or postpartum periods.

    Treatment: Tight postpartum blood pressure control

  • Retrospective observational armNo study treatment, for comparison

    The retrospective cohort will include all patients diagnosed with chronic hypertension or pregnancy-induced hypertensive (PIH) disorders at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center in the past two years, including those presenting to the Emergency Department or readmitted for hypertensive disorders, during the immediate six weeks postpartum.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 April 2024